https://www.selleckchem.com/pr....oducts/etomoxir-na-s
The promising therapeutic strategy for the treatment of peripheral artery disease (PAD) is to restore blood supply and promote regeneration of skeletal muscle regeneration. Increasing evidence revealed that prostaglandin E (PGE ), a lipid signaling molecule, has significant therapeutic potential for tissue repair and regeneration. Though PGE has been well reported in tissue regeneration, the application of PGE is hampered by its short half-life in vivo and the lack of a viable system for sustained release of PGE . In this study